Pharmacists in Highland, CA Accepting Medicare

28 Pharmacists found. Showing 21 - 28

Ashley H Yu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27951 Baseline St, Highland, CA 92346 Phone: 909-864-5701    Fax: 909-864-5981

Bhavna Zaroo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27310 Baseline St, Highland, CA 92346 Phone: 909-862-4048

Baraa Taleb, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4210 Highland Ave, Highland, CA 92346 Phone: 909-425-8687

Olajuwon Abijo Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 4210 Highland Ave, Highland, CA 92346 Phone: 951-269-8188

Dr. Richard P Mann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27951 Baseline St, Highland, CA 92346 Phone: 909-864-5701

Thomas Battaile Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3694 Highland Ave, Suite 27, Highland, CA 92346 Phone: 909-425-0311    Fax: 909-862-1199

Dr. Brianna Rose Delpilar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2692 Highland Ave., Spc. 20, Highland, CA 92346 Phone: 909-855-1814

Lara Lipskey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27310 Baseline St, Highland, CA 92346 Phone: 909-862-4048

News Archive

Omitting postoperative radiation therapy did not compromise survival for older HR-positive breast cancer patients

Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.

NIDDK publishes strategic plan for research into benign prostate

For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.

Children's Hospital Los Angeles ranked among nation's top 5 again

For the third straight year, Children's Hospital Los Angeles is ranked among the top five children's hospitals in the country, a distinction that recognizes the hospital's clinical expertise and the quality and breadth of its patient care.

Korean FDA grants pre-market clearance for ETView's VivaSight‐SL airway management solutions

ETView today announced that the Korean Food and Drug Administration ("KFDA") has granted pre-market clearance for VivaSight‐SL. With KFDA clearance, ETView plans to immediately initiate market launch of VivaSight‐SL. ETView also announced a distribution agreement with ChinooMTech Company.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)